WebJun 17, 2024 · BOSTON, June 17, 2024 – Dewpoint Therapeutics, the biomolecular condensates company, has announced the appointments of Olivier Brandicourt and Jürgen Eckhardt to its board of directors. An accomplished pharmaceutical industry leader, Dr. Brandicourt has served as CEO of both Sanofi S.A. and Bayer HealthCare AG. WebMar 23, 2024 · They said the same thing: Dewpoint Therapeutics." Young brokered a meeting between Nathwani and Uli Stilz, the Boston-based vice president of Novo Nordisk. The two companies found a deal.
Dewpoint Therapeutics partners with Novo Nordisk to explore …
WebDewpoint Therapeutics 6,533 followers on LinkedIn. Dewpoint is translating condensate biology into medicine. Dewpoint is the first company to apply the emerging understanding of biomolecular ... WebVolastra Therapeutics and Dewpoint Therapeutics Partner to Discover Novel Condensate Modulators for Cancer Treatment NEW YORK and BOSTON, March 9, 2024 /PRNewswire/ -- Volastra Therapeutics and Dewpoint Therapeutics today announced a research and development partnership to discover novel modulators of biomolecular condensates to … iol astigmatism correction
Dewpoint Therapeutics granted foundational platform …
WebOct 13, 2024 · BOSTON, October 13, 2024 — Dewpoint Therapeutics, the biomolecular condensates company, today announced it has appointed Ameet Nathwani, M.D., as Chief Executive Officer and member of the Board of Directors. “We are extremely fortunate to … WebDewpoint Therapeutics Feb 2024 - Jul 2024 1 year 6 months. Boston, Massachusetts, United States Chief Financial Officer Sema4 Nov 2024 - … WebAn Integrated Discovery Platform. To lead the way in the discovery of transformative condensate modulating therapies, Dewpoint has developed a fully integrated suite of technologies. We combine expertise from … iola thedacare